Heart failure carries a substantial burden with an estimated direct and indirect cost in the US of $26.9 billion.
Evidence-based care offers opportunities to reduce mortality, morbidity and re-hospitalization rates for patients with HF.
Reducing the frequency of readmissions may afford hospitals an opportunity to reduce cost and improve productivity.
